Medite Cancer Diagnostics, Inc. (MDIT)

Medite Cancer Diagnostics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	May 2, 2025	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Market Capitalization	0	9	11	24	58	11
Market Cap Growth	21.66%	-19.96%	-55.65%	-58.25%	451.30%	-88.68%
Enterprise Value	-	13	16	28	64	13
Last Close Price	0.00	0.30	0.51	1.15	3.01	263.00
PE Ratio	-	-	-	-	-	194.82
PS Ratio	0.00	1.26	1.16	2.45	5.28	1.06
PB Ratio	0.00	1.49	1.34	2.64	6.88	4.01
P/TBV Ratio	-	-	-	-	-	4.01
EV/Sales Ratio	-	1.93	1.75	2.80	5.78	1.26
EV/EBITDA Ratio	-	-	-	-	-	25.28
EV/EBIT Ratio	-	-	-	-	-	42.65
Debt / Equity Ratio	0.94	0.94	0.55	0.43	0.46	1.64
Debt / EBITDA Ratio	-	-	-	-	-	8.69
Asset Turnover	0.44	0.41	0.51	0.53	0.82	1.29
Inventory Turnover	1.68	2.14	1.63	1.88	1.95	1.59
Quick Ratio	0.20	0.14	0.20	0.39	0.33	0.42
Current Ratio	1.11	0.92	0.73	0.92	0.85	1.54
Return on Equity (ROE)	-73.70%	-98.72%	-25.17%	-9.76%	-12.65%	2.15%
Return on Assets (ROA)	-13.68%	-24.16%	-5.78%	-2.02%	-1.84%	2.37%
Return on Capital (ROIC)	-19.47%	-34.29%	-8.13%	-2.94%	-2.56%	2.79%
Return on Capital Employed (ROCE)	-	-	-	-	-	7.00%
Earnings Yield	-63127.84%	-79.25%	-20.14%	-3.55%	-1.21%	0.51%
FCF Yield	-61729.40%	-43.09%	-11.23%	-2.46%	-2.33%	-4.74%
Buyback Yield / Dilution	-99.94%	-23.40%	-6.08%	-11.47%	-23.34%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.